All articles by Anthony King – Page 2
-
BusinessWeight-loss drugmakers bet billions on boosting supplies
Eli Lilly and Novo Nordisk invest to expand in-house manufacturing of GLP-1 drugs
-
NewsMetallic nodules sought by deep sea miners could be making oxygen in the depths
Water-splitting at the bottom of the Pacific holds intriguing implications for the origin of life on Earth – and further afield
-
ResearchNew gene-editing tool found in bacterium could carry out extensive genome remodelling
Highly selective mechanism can insert, remove and flip large portions of DNA
-
-
NewsNineteen journals shut down by Wiley following delisting and paper mill problems
Issues with manufactured manuscripts are a problem the whole publishing industry faces
-
NewsFour new research centres launched with €104 million from Science Foundation Ireland
Advanced manufacturing, neurological disease and bioeconomy concept to support 600 roles
-
BusinessPan-cancer approval shows huge potential for antibody–drug conjugates
Enhertu gains approval based on gene expression rather than tumour location
-
ResearchHow HIV drugs have changed over the decades
From one big pill that only prolonged lives a few months, through the 20 pills a day years to modern combination therapies, treating HIV is a science success story
-
ResearchMicrobial enzymes cut a path towards universal blood for transfusions
Slicing off glycans revealed new, previously unknown antigens that must be removed to produce O-type blood
-
NewsPlastic chemicals review reveals thousands of compounds have little safety data
Existing scientific knowledge on hazards of plastic chemicals compiled in dossier for decision makers
-
ResearchConcerns raised over health effects of chemicals leaching from food packaging
Gene assays reveal disruption to cell receptors crucial for hormonal and metabolic control
-
FeatureHow microbes influence our brain health
Our gut microbiome has been linked to conditions such as Parkinson’s and Alzheimer’s. Anthony King reports on the connections
-
BusinessChemours suspends chief and senior executives over accounting issues
Auditors to investigate issues around whistleblowing and financial management
-
BusinessBig deals confirm renewed interest in radiopharmaceuticals
Acquisitions of RayzeBio and Point Biopharma highlight the potential of targeting radioactivity directly to tumour cells
-
ResearchStriking reptilian fossil discovered in 1931 found to be fake
280-million-year-old lizard ‘fossil’ was mostly painted on
-
BusinessNovo Holdings to buy contract manufacturer Catalent for $16.5 billion
Parent firm will then sell on three manufacturing sites to Novo Nordisk to boost capacity for diabetes and weight loss drugs
-
ResearchRare medical transmission of Alzheimer’s disease from donor to patient discovered
Human growth hormone extracted from cadavers passed disease protein to at least five people
-
BusinessNuclear power expansion plans highlight fuel bottlenecks
Western governments look to overcome Russian dominance of key uranium processing steps
-
BusinessDanaher completes $5.7 billion Abcam acquisition
Deal proceeded despite significant opposition from founder and ex-chief Jonathan Milner
-
BusinessLife-saving cancer gene therapy under investigation after being linked to rare secondary cancers
US drug agency examining six CAR-T therapies after reports of T-cell malignancies